Sarah Condella serves as Executive at EXACT SCIENCES CORP, where they oversee executive responsibilities. Since joining the company, Sarah Condella has executed 80 insider transactions totaling $5.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 23, 2025 involved receiving (via award) 8,000 shares valued at $0.
Sarah Condella currently holds 132,894 shares of EXACT SCIENCES CORP (EXAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Condella has been a net seller of EXAS stock. They have purchased $0 and sold $5.8M worth of shares.
Sarah Condella's most recent insider trade was on Dec 23, 2025, when they sold 8,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 23, 2025 | EXAS | $361.9K | Payment | 3,554 | $101.82 | Discretionary |
| Dec 23, 2025 | EXAS | $0 | Option Exercise | 7,560 | $N/A | Discretionary |
| Dec 23, 2025 | EXAS | $0 | Award | 34,018 | $N/A | Discretionary |
| Dec 23, 2025 | EXAS | $1.6M | Payment | 15,989 | $101.82 | Discretionary |
| Dec 23, 2025 | EXAS | $1.1M | Payment | 11,194 | $101.82 | Discretionary |
| Dec 23, 2025 | EXAS | $382.8K | Payment | 3,760 | $101.82 | Discretionary |
| Dec 23, 2025 | EXAS | $189.3K | Payment | 1,859 | $101.82 | Discretionary |
| Dec 23, 2025 | EXAS | $0 | Option Exercise | 3,955 | $N/A | Discretionary |
| Dec 23, 2025 | EXAS | $0 | Option Exercise | 23,817 | $N/A | Discretionary |
| Dec 23, 2025 | EXAS | $568.4K | Payment | 5,582 | $101.82 | Discretionary |
| May 1, 2024 | EXAS | $6.1K | Sale | 102 | $60.15 | Planned |
| Apr 30, 2024 | EXAS | $21.3K | Award | 708 | $30.02 | Planned |
| Apr 30, 2024 | EXAS | $0 | Award | 218 | $N/A | Planned |
| Apr 1, 2024 | EXAS | $140.0K | Sale | 2,000 | $70.00 | Planned |
| Mar 28, 2024 | EXAS | $140.0K | Sale | 2,000 | $70.00 | Planned |
| Mar 1, 2024 | EXAS | $102.3K | Sale | 1,724 | $59.32 | Planned |
| Feb 29, 2024 | EXAS | $0 | Option Exercise | 3,779 | $N/A | Planned |
| Feb 27, 2024 | EXAS | $107.0K | Sale | 1,880 | $56.89 | Planned |
| Feb 26, 2024 | EXAS | $0 | Option Exercise | 3,954 | $N/A | Planned |
| Feb 23, 2024 | EXAS | $61.0K | Sale | 1,021 | $59.72 | Planned |
| Feb 22, 2024 | EXAS | $60.6K | Sale | 1,013 | $59.78 | Planned |
| Feb 21, 2024 | EXAS | $66.4K | Sale | 1,079 | $61.50 | Planned |
| Feb 21, 2024 | EXAS | $0 | Award | 2,034 | $N/A | Planned |
| Feb 20, 2024 | EXAS | $0 | Option Exercise | 2,248 | $N/A | Planned |
| Feb 15, 2024 | EXAS | $59.3K | Sale | 965 | $61.43 | Planned |
| Feb 14, 2024 | EXAS | $0 | Option Exercise | 2,031 | $N/A | Planned |
| Jan 2, 2024 | EXAS | $147.0K | Sale | 2,000 | $73.50 | Planned |
| Dec 14, 2023 | EXAS | $140.0K | Sale | 2,000 | $70.00 | Planned |